384 Chapter 12 438. Gerashchenko D, Kohls MD, Greco M, Waleh NS, Salin-Pascual R, Kilduff TS, et al. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci. 2001;21(18):7273-83. 439. Barateau L, Lopez R, Arnulf I, Lecendreux M, Franco P, Drouot X, et al. Comorbidity between central disorders of hypersomnolence and immune-based disorders. Neurology. 2017;88(1):93-100. 440. Chen G, Wang W, Wu H, Zhao X, Kang X, Ren J, et al. Disrupted topological properties of structural brain networks present a glutamatergic neuropathophysiology in people with narcolepsy. Sleep. 2024. 441. Antelmi E, Pizza F, Franceschini C, Ferri R, Plazzi G. REM sleep behavior disorder in narcolepsy: A secondary form or an intrinsic feature? Sleep Med Rev. 2020;50:101254. 442. Huang YS, Liu FY, Lin CY, Hsiao IT, Guilleminault C. Brain imaging and cognition in young narcoleptic patients. Sleep Med. 2016;24:137-44. 443. Gool JK, Van Heese EM, Lammers GJ, R. F, Joo EY, Schwartz S, et al. The NeuroImaging Consortium on Central Disorders of Hypersomnolence (NICHY): A Global Meta- and Mega-analysis Framework to Unravel the Neural Correlates of Central Disorders of Hypersomnolence. European Narcolepsy Days; Bologna, Italy2022. 444. Yeo BT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, Hollinshead M, et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol. 2011;106(3):1125-65. 445. Sporns O. Graph theory methods: applications in brain networks. Dialogues Clin Neurosci. 2018;20(2):111-21. 446. Schinkelshoek MS, de Wit K, Bruggink V, Fronczek R, Lammers GJ. Daytime sleep state misperception in a tertiary sleep centre population. Sleep Med. 2020;69:7884. 447. Reddy OC, van der Werf YD. The Sleeping Brain: Harnessing the Power of the Glymphatic System through Lifestyle Choices. Brain Sci. 2020;10(11). 448. Jarvela M, Kananen J, Korhonen V, Huotari N, Ansakorpi H, Kiviniemi V. Increased very low frequency pulsations and decreased cardiorespiratory pulsations suggest altered brain clearance in narcolepsy. Commun Med (Lond). 2022;2:122. 449. Mestre H, Tithof J, Du T, Song W, Peng W, Sweeney AM, et al. Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension. Nat Commun. 2018;9(1):4878. 450. Gumeler E, Aygun E, Tezer FI, Saritas EU, Oguz KK. Assessment of glymphatic function in narcolepsy using DTI-ALPS index. Sleep Med. 2023;101:522-7. 451. Ringstad G. Glymphatic imaging: a critical look at the DTI-ALPS index. Neuroradiology. 2024;66(2):157-60. 452. Dauvilliers Y, Barateau L. Narcolepsy and Other Central Hypersomnias. Continuum (Minneap Minn). 2017;23(4, Sleep Neurology):989-1004. 453. Kerr WT. Working Toward Clinically Meaningful Subtypes of Hypersomnolence Using Data-Driven Phenotyping, but Not There Yet. Neurology. 2022;98(23):961-2. 454. Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560-79. 455. Justinussen JL, Egebjerg C, Kornum BR. How hypocretin agonists may improve the quality of wake in narcolepsy. Trends Mol Med. 2023;29(1):61-9. 456. Dauvilliers Y, Mignot E, Del Rio Villegas R, Du Y, Hanson E, Inoue Y, et al. Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1. N Engl J Med. 2023;389(4):309-21.
RkJQdWJsaXNoZXIy MjY0ODMw